Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Crohn's Disease
Related studies linked through entity extraction aliases.
An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
- Status
- COMPLETED
- Phase
- N/A
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
- Status
- WITHDRAWN
- Phase
- N/A
Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease
- Status
- COMPLETED
- Phase
- NA
A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
- Status
- COMPLETED
- Phase
- NA
Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease
- Status
- COMPLETED
- Phase
- NA
Remicade® Crohn's Disease Registry Across Canada (Study P02793)
- Status
- TERMINATED
- Phase
- N/A
Treatment With Infliximab in a Medical Setting (Study P05587)
- Status
- TERMINATED
- Phase
- PHASE4
The Effect of Infliximab on Sperm Quality
- Status
- UNKNOWN
- Phase
- N/A
Extension Study of Semapimod 60 mg IV x 3 Days
- Status
- COMPLETED
- Phase
- PHASE2
Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo
- Status
- COMPLETED
- Phase
- PHASE2
Laquinimod Phase IIa Study in Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of PET CT in the Management of Patients With Crohn's Disease.
- Status
- UNKNOWN
- Phase
- PHASE4
Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)
- Status
- COMPLETED
- Phase
- N/A
Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)
- Status
- COMPLETED
- Phase
- N/A
Post Marketing Surveillance of Remicade
- Status
- COMPLETED
- Phase
- N/A